Last reviewed · How we verify

NCT06339996

Male Supplements for Sperm Quality and Aging

Recruiting now NA Last updated 2 August 2024
What this trial tests

NA trial testing Male supplement in Unrecognized Condition in 50 participants. Currently enrolling.

Timeline
26 March 2024
Primary endpoint
31 October 2025
31 December 2025

Quick facts

Lead sponsorKaohsiung Veterans General Hospital.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date26 March 2024
Primary completion31 October 2025
Estimated completion31 December 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Veterans General Hospital.

Who can join

Adults 30 to 50, male only, with Unrecognized Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effects of a new supplement on sperm quality in men with poor sperm quality. Fifty patients will receive the supplement for three months, followed by semen analysis and assessment of sperm aging and mitochondrial function. Changes in sexual function and aging symptoms will also be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Unrecognized Condition

Currently open trials in the same condition.

Other Kaohsiung Veterans General Hospital. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06339996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing